HOME >> BIOLOGY >> NEWS
'Good' bacteria could save patients from infection infection by deadlier ones

Jerusalem Can it be that the stress on the use of antiseptics and antibiotics in hospitals is actually putting patients at a greater risk of suffering fatal bacterial infection?

Yes, argues Mark Spigelman, a visiting professor at the Sanford F. Kuvin Center for the Study of Infectious and Tropical Diseases at the Hebrew University of Jerusalem's Faculty of Medicine. Prof. Spigelman points to a recent BBC report on the poor record of bacterial infections in patients (the worst in Europe) in British public hospitals, especially involving the deadly MRSA (methacillin resistant staphylococcus aureus) bacteria. Despite being around for 40 years, these bacteria are still basically found only in hospitals. The question Spigelman asks is why?

Spigelman, who is also a visiting professor at University College London, argues in an article appearing in the current online edition of the Annals of the Royal College of Surgeons of England that the stress on antibiotics and scrubbing with antiseptic soap may actually open an avenue for the more virulent forms of bacteria to attack patients. This is so because these "preventive" measures destroy beneficial bacteria, while at the same time the more "nasty" bacteria are often able to survive by adapting themselves to the pharmacological means used against them.

Since different strains of bacteria do not generally occupy the same surfaces, it would be better, argues Spigelman, to allow the harmless or "good" bacteria to live in the hospital environment, thus creating a kind of natural protection against the deadlier strains.

To test his hypothesis, Spigelman suggests experimenting with antibiotic-free hospitals in which harmless bacteria would be free to exist and there would be no environmental "incentive" for the more virulent strains to develop. Any patients needing antibiotics would be transferred to hospitals where they are in use. Doctors in the antibiotic-free hospitals would not enter and tre
'"/>

Contact: Jerry Barach
jerryb@savion.huji.ac.il
972-2-588-2904
The Hebrew University of Jerusalem
2-Nov-2005


Page: 1 2

Related biology news :

1. In limiting life span, study finds booming bacteria innocent
2. Cornell scientists link E. coli bacteria to Crohns disease
3. Pets could be source of multiresistant bacteria infections in humans, MU researchers investigate
4. Researchers watch antibiotics, bacteria meet at atomic level
5. A new plant-bacterial symbiotic mechanism promising
6. Piecing together the cyanobacteria puzzle
7. New research shows vaginal bacteria vary among healthy women, need customized treatment
8. New way to target and kill antibiotic-resistant bacteria found
9. UCF professor finds bacterial pathogen may be key to understanding cancer development
10. Helping chlorine-eating bacteria clean up toxic waste
11. Researchers discover acquired DNA key to certain bacterial infection

Post Your Comments:
(Date:12/19/2014)... 18, 2014 Research and Markets ... the "iPhone 5S Fingerprint Sensor - Apple/AuthenTec ... to their offering. ... AuthenTec in July 2012, Apple introduced the fingerprint ... currently the only device of Apple incorporating such ...
(Date:12/19/2014)... , Dec. 18, 2014 Research and Markets ... of the "Micro Market Monitor: North America Perimeter ... http://photos.prnewswire.com/prnh/20130307/600769 The ... at a CAGR of 3.6% from 2014 to 2019. ... this market, Canada is expected ...
(Date:12/19/2014)... MOUNTAIN VIEW, Calif. , Dec. 18, 2014 /PRNewswire/ ... the publication of a study that pinpoints fine-scale differences ... the United States . Since immigrants ... the United States has served as ... study illuminates how American history and the ongoing mixing ...
Breaking Biology News(10 mins):iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & Sapphire - Technology Report 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 323andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4
(Date:12/19/2014)... PA (PRWEB) December 19, 2014 ... leading developer and manufacturer of needle-free injection technology, ... agreement with Immunomic Therapeutics, Inc. (“ITI”) for ITI ... device with its LAMP™ vaccine platform. , ... an exclusive Worldwide license to the Biojector®-2000 that ...
(Date:12/19/2014)... Charm Sciences is pleased to announce that its ... M1 in raw commingled milk is the first lateral ... peer reviewed report of the validation by Technology and ... Fisheries Research (ILVO-T&V) has been published by the Taylor ... toxic aflatoxin and a known carcinogen, can be passed ...
(Date:12/19/2014)... BioPlus Specialty Pharmacy (BioPlus), one of the ... Maroulis, Pharm.D. to the newly created position of Vice ... position, Dr. Maroulis will continue to manage the entire ... multi-site pharmacies as the company expands. Dr. Maroulis has ... he has served in many different capacities in the ...
(Date:12/19/2014)... Dec. 19, 2014 Naurex Inc., a biopharmaceutical ... for diseases of the central nervous system, today announced ... executive officer, will present at the 33 rd ... take place at 3:00 p.m. PST on Tuesday, January ... San Francisco, Calif. ...
Breaking Biology Technology:Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 2Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 3Charm Sciences Achieves Independent Validation of First 15 Minute Quantitative Screening Method for Aflatoxin M1 2BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2Naurex to Present at 33rd Annual J.P. Morgan Healthcare Conference 2
Cached News: